Evaluation of release enhancement of efavirenz through poloxamer solid dispersions
DOI:
https://doi.org/10.1590/s2175-97902026e24641Keywords:
Efavirenz, USP Apparatus IV, Solid dispersion, Poloxamer, SolubilityAbstract
Poloxamers are triblock copolymers commonly used in pharmaceutical formulation development to enhance the solubility of poorly water-soluble compounds. The present study investigated the efficiency of the hydrophilic carriers, poloxamer 188 (P188) and poloxamer 407 (P407), in preparing solid dispersions (SDs) of efavirenz (EFV), a BCS Class II antiretroviral. The SDs were prepared at a 1:3 drug:copolymer ratio (w/w) using the solvent evaporation method and characterized through solubility assays (shake-flask method) and solid-state analytical techniques, including DSC, TGA, FTIR, and XRPD. Additionally, the differences between P188 and P407 in effectively improving EFV dissolution across the physiological pH range were evaluated using a flow-through cell apparatus (USP Apparatus IV). XRPD results confirmed that both carriers stabilized EFV in its amorphous form within the SDs after 30-day stability studies. The saturation solubility of SDs prepared with P407 was nearly four times higher than those with P188 and approximately 2,000 times greater than the solubility of pure EFV (10 μg/mL). Consistent with the solubility results, dissolution testing demonstrated that P407 generally promoted higher EFV dissolution levels than P188 at all evaluated pH ranges.
Downloads
References
Alves LDS, De La Roca Soares MF, De Albuquerque CT, Da Silva ER, Vieira ACC, Fontes DAF, et al. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohydr Polym. 2014;104(1):166–74.
Bodratti A, Alexandridis P. Formulation of Poloxamers for Drug Delivery. J Funct Biomater. 2018;9(1):11.
Burnett DJ, Garcia AR, Heng JYY, Thielmann F, Lan Y, Ali S, et al. Moisture Sorption Properties of Different Poloxamer Grades. AAPS Annu Meet. 2015;629(2004):18103.
Chaudhari SP, Dugar RP. Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Deliv Sci Technol. 2017;41:68–77.
Colombo M, de Lima Melchiades G, Michels LR, Figueiró F, Bassani VL, Teixeira HF, et al. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. AAPS PharmSciTech. 2019;20(3):106.
Costa BLA, Sauceau M, Del Confetto S, Sescousse R, Ré MI. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®. Eur J Pharm Biopharm. 2019;142:300–6.
Cristofoletti R, Nair A, Abrahamsson B, Groot DW, Kopp S, Peter L, et al. Biowaiver Monographs for Immediumte Release Solid Oral Dosage Forms: Efavirenz. J Pharm Sci. 2013;102(2):318–29.
Dahan A, Miller JM, Amidon GL. Prediction of solubility and permeability class membership: Provisional BCS classification of the world’s top oral drugs. AAPS J. 2009;11(4):740–6.
Davis MT, Egan DP, Kuhs M, Albadarin AB, Griffin CS, Collins JA, et al. Amorphous solid dispersions of BCS class II drugs: A rational approach to solvent and polymer selection. Chem Eng Res Des. 2016;110:192–9.
Dezani AB, Dezani TM, Ferreira JCF, Serra CH dos R. Solubility evaluation of didanosine: a comparison between the equilibrium method and intrinsic dissolution for biopharmaceutics classification purposes. Brazilian J Pharm Sci. 2017;53(2):1–8.
Dugar RP, Gajera BY, Dave RH. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407. AAPS PharmSciTech. 2016;17(6):1428–40.
Eloy JO, Marchetti JM. Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methods. Powder Technol. 2014;253:98–106.
Fandaruff C, Araya-Sibaja AM, Pereira RN, Hoffmeister CRD, Rocha HVA, Silva MAS. Thermal behavior and decomposition kinetics of efavirenz under isothermal and non-isothermal conditions. J Therm Anal Calorim. 2014b;115:2351–6.
Fandaruff C, Rauber GS, Araya-Sibaja AM, Pereira RN, De Campos CEM, Rocha HVA, et al. Polymorphism of anti-HIV drug efavirenz: Investigations on thermodynamic and dissolution properties. Cryst Growth Des. 2014a;14(10):4968–75.
Fontes DAF, Lyra MAM de, Andrade JKF de, Schever GCR de M, Rolim LA, Silva TG da, et al. CaAl-layered double hydroxide as a drug delivery system: effects on solubility and toxicity of the antiretroviral efavirenz. J Incl Phenom Macrocycl Chem. 2016;85:281–8.
Fotaki N. Flow-Through Cell Apparatus (USP Apparatus 4): Operation and Features. Dissolution Technol. 2011;18(4):46–9.
Fusco S, Borzacchiello A, Netti PA. Perspectives on: PEO-PPO-PEO triblock copolymers and their biomedical applications. J Bioact Compat Polym. 2006;21(2):149–64.
Garala K, Joshi P, Patel J, Ramkishan A, Shah M. Formulation and evaluation of periodontal in situ gel. Int J Pharm Investig. 2013;3(1):29.
Hoffmeister CRD, Fandaruff C, da Costa MA, Cabral LM, Pitta LR, Bilatto SER, et al. Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation. Eur J Pharm Sci. 2017;99:310–7.
Huang S, Williams RO. Effects of the Preparation Process on the Properties of Amorphous Solid Dispersions. AAPS PharmSciTech. 2018;19(5):1971–84.
Jørgensen JR, Mohr W, Rischer M, Sauer A, Mistry S, Müllertz A, et al. Stability and intrinsic dissolution of vacuum compression molded amorphous solid dispersions of efavirenz. Int J Pharm. 2023;632:122564.
Karolewicz B, Gajda M, Górniak A, Owczarek A, Mucha I. Pluronic F127 as a suitable carrier for preparing the imatinib base solid dispersions and its potential in development of a modified release dosage forms: Thermal, spectroscopic, microscopic, and dissolution studies. J Therm Anal Calorim. 2017;130(1):383–90.
Koh PT, Chuah JN, Telekar M, Gorajana A, Garg S. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. Indian J Pharm Sci. 2013;75(3):291–301.
Lavra ZMM, Pereira de Santana D, Ré MI. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus. Drug Dev Ind Pharm. 2017;43(1):42–54.
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47–60.
Li Y, Zhao X, Zu Y, Zhang Y. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization. Int J Pharm. 2015;490(1–2):324–33.
Mahapatra S, Thakur TS, Joseph S, Varughese S, Desiraju GR. New solid state forms of the anti-HIV drug efavirenz. Conformational flexibility and high Z′ issues. Cryst Growth Des. 2010;10(7):3191–202.
Marques MM, Rezende CA, Lima GC, Marques ACS, Prado LD, Leal KZ, et al. New solid forms of efavirenz: Synthesis, vibrational spectroscopy and quantum chemical calculations. J Mol Struct. 2017;1137:476–84.
Martinez MN, Amidon GL. A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals. J Clin Pharmacol. 2002;42(6):620–43.
Medarević DP, Kachrimanis K, Mitrić M, Djuriš J, Djurić Z, Ibrić S. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol. 2016;21(3):268–76.
Mishra S, Tandon P, Ayala AP. Study on the structure and vibrational spectra of efavirenz conformers using DFT: Comparison to experimental data. Spectrochim Acta Part A Mol Biomol Spectrosc. 2012;88:116–23
Monteiro LM, Löbenberg R, Cotrim PC, Barros de Araujo GL, Bou-Chacra N. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases. Biomed Res Int. 2017;2017:1–11.
Mugheirbi NA, O’Connell P, Serrano DR, Healy AM, Taylor LS, Tajber L. A Comparative Study on the Performance of Inert and Functionalized Spheres Coated with Solid Dispersions Made of Two Structurally Related Antifungal Drugs. Mol Pharm. 2017;14(11):3718–28.
Pawar J, Tayade A, Gangurde A, Moravkar K, Amin P. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach. Eur J Pharm Sci. 2016;88:37–49.
Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Babu RJ. Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement. J Pharm Sci. 2012;101(9):3456–64.
Schittny A, Philipp-Bauer S, Detampel P, Huwyler J, Puchkov M. Mechanistic insights into effect of surfactants on oral bioavailability of amorphous solid dispersions. J Control Release. 2020;320:214–25.
Serra CH dos R, Storpirtis S. Comparação de perfis de dissolução da cefalexina através de estudos de cinética e eficiência de dissolução ( ED %). Brazilian J Pharm Sci. 2007;43:79–88.
Shirwaiker RA, Purser MF, Wysk RA. Scaffolding hydrogels for rapid prototyping based tissue engineering. In: Rapid Prototyping of Biomaterials. Elsevier; 2014. p. 176–200.
UNAIDS Brasil - Website institucional do Programa Conjunto das Nações Unidas sobre HIV/AIDS (UNAIDS) no Brasil. [Internet]. [cited 2024 Jul 25]. Available from: https://unaids.org.br/
Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263–71.
Downloads
Published
Data Availability Statement
Use of data not disclosed.
Issue
Section
License
Copyright (c) 2026 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
How to Cite
Funding data
-
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant numbers Process #304477/2022-2
